Showing 1 - 20 results of 23 for search '"Koto, Tokyo"', query time: 0.15s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16

    The Incidence and Management of Cancer-Related Anorexia During Treatment with Vascular Endothelial Growth Factor Receptor-Tyrosine Kinase Inhibitors by Takahashi S, Matsumoto K, Ohba K, Nakano Y, Miyazawa Y, Kawaguchi T

    Published 2023-09-01
    “…Shunji Takahashi,1 Koji Matsumoto,2 Kojiro Ohba,3 Yasuhiro Nakano,4 Yasushi Miyazawa,5 Takumi Kawaguchi6 1Department of Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan; 2Department of Medical Oncology, Hyogo Cancer Center, Akashi, Japan; 3The Department of Urology and Renal Transplantation, Nagasaki University Hospital, Nagasaki, Japan; 4Department of Pharmacy, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan; 5Department of Clinical Nutrition, Tokyo Medical University Hospital, Tokyo, Japan; 6Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, JapanCorrespondence: Shunji Takahashi, Department of Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto, Tokyo, 135-8550, Japan, Tel +81-3-3520-0111, Fax +81-3-3520-0141, Email s.takahashi-chemotherapy@jfcr.or.jpAbstract: Cancer-related anorexia is a common complication and frequently occurs in cancer patients treated with vascular endothelial growth factor receptor-tyrosine kinase inhibitors (VEGFR-TKIs). …”
    Get full text
    Article
  17. 17
  18. 18
  19. 19
  20. 20